...
首页> 外文期刊>Aquaculture Research >Effect of route of administration and carrier on bioavailability and kinetics of astaxanthin in Atlantic salmon Salmo salar L.
【24h】

Effect of route of administration and carrier on bioavailability and kinetics of astaxanthin in Atlantic salmon Salmo salar L.

机译:给药途径和载体对大西洋鲑鱼Salmo salar L中虾青素生物利用度和动力学的影响

获取原文
获取原文并翻译 | 示例

摘要

This study examined astaxanthin bioavailability and kinetics in adult Atlantic salmon Salmo salar L., following two different routes of astaxanthin administration (oral vs. intraperitoneal (i.p.) injection) using two different carriers of the pigment (gelatin vs. sesame oil). The dorsal aorta of adult Atlantic salmon (mean initial weight 950 g) was cannulated. The fish received a single dose of astaxanthin (572 mug kg(-1)) in sesame oil or (514 mug kg(-1)) in gelatin via the oral or i.p. route, Plasma was sampled regularly up to 72 h post oral administration and up to 510 h post i.p. injection. The astaxanthin concentration-time curves from plasma were best fit to a one-compartment pharmacokinetic model for each of the four treatments. The gelatin carrier resulted in higher availability of astaxanthin compared to the sesame oil carrier. The bioavailability for astaxanthin in sesame oil was only 38.7% of that in gelatin by i.p. injection, and only 53.5% of that in gelatin by oral administration. Higher availability of astaxanthin was observed when i.p. injection was used compared to oral administration. The bioavailability for astaxanthin administered orally was only 12% of that by i.p. injection in sesame oil, and only 8.7% of that by i.p. injection in gelatin.
机译:这项研究使用两种不同的色素载体(明胶与芝麻油),按照两种不同的虾青素施用途径(口服与腹膜内(i.p.)注射)检查了成年大西洋鲑Salmo salar L.中虾青素的生物利用度和动力学。插入成年大西洋鲑(平均初始重量950 g)的背主动脉。这条鱼通过口服或腹膜内注射单剂量虾青素(572马克/千克(-1))的麻油或(514马克/千克(-1))的明胶。口服后最多72小时和腹腔内最多510小时后定期取样血浆。注射。来自血浆的虾青素浓度-时间曲线最适合四种治疗方法中的每一种的一室药代动力学模型。与芝麻油载体相比,明胶载体可提高虾青素的利用率。 i.p.测定,芝麻油中虾青素的生物利用度仅为明胶中的38.7%。通过口服给药,只有明胶的53.5%。当腹膜内注射时,虾青素的利用率更高。与口服相比,使用注射剂。口服给予虾青素的生物利用度仅为腹膜内注射的生物利用度的12%。注射芝麻油,经腹腔注射仅占8.7%。明胶注射。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号